Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria-Luise Scherzer"'
Publikováno v:
Clinical Ophthalmology, Vol 2010, Iss default, Pp 459-466 (2010)
Norbert Pfeiffer1, Maria-Luise Scherzer2, Hubert Maier3, Sonja Schoelzel4, Mark C Jasek5, Jeanette A Stewart6, William C Stewart6 On behalf of the DuoTravMED study group1Johannes Gutenberg-Universität Mainz, Mainz, Germany; 2Regenstauf, Germany; 3Ge
Externí odkaz:
https://doaj.org/article/5f3342e3d4c646aeae3e9f5eab6063f8
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Romeo Altafini,1 Maria-Luise Scherzer,2 Douglas A Hubatsch,3 Paolo Frezzotti4 1Glaucoma Segment Unit, “San Bortolo” Hospital, Vicenza, Italy; 2Private Practice, Regenstauf, Germany; 3Alcon Laboratories, Inc., Fort Worth, TX, USA; 4Ophthalmic Unit
Publikováno v:
Advances in Therapy. 28:661-670
Patients with glaucoma or ocular hypertension who do not achieve target intraocular pressure (IOP) using one hypotensive agent are often transitioned to combination therapy. Travoprost 0.004%/timolol 0.5% fixed combination (TTFC) has shown efficacy i
Autor:
Sonja Schoelzel, Mark C Jasek, Maria-Luise Scherzer, William C. Stewart, Norbert Pfeiffer, Hubert Maier, Jeanette A. Stewart
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Norbert Pfeiffer1, Maria-Luise Scherzer2, Hubert Maier3, Sonja Schoelzel4, Mark C Jasek5, Jeanette A Stewart6, William C Stewart6 On behalf of the DuoTravMED study group1Johannes Gutenberg-Universität Mainz, Mainz, Germany; 2Regenstauf, Germany; 3Ge
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Dietmar Schnober,1 Douglas A Hubatsch,2 Maria-Luise Scherzer3 1Private Ophthalmology Practice, Werdohl, Germany; 2Alcon Laboratories, Inc., Fort Worth, TX, USA; 3Private Ophthalmology Practice, Regenstauf, Germany Purpose: To determine the efficacy a